Efficacy of Pregabalin in the Treatment of Orofacial Neuropathic Pain.
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2015
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 15 Feb 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 16 Apr 2010 Planned end date changed from 1 Aug 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.
- 02 Mar 2009 New trial record